Tag:
Coridon
Latest Headlines
Latest Headlines
Coridon HSV-2 vaccine shows 100% efficacy
Brisbane, Australia-based biotech Coridon has developed a DNA vaccine for herpes simplex virus 2 that showed 100% efficacy in a preclinical trial. Thanks to financial backing from Allied Healthcare
Australia's Coridon attracts billionaire investment
Andrew Forrest, billionaire CEO of the Australian mining company Fortescue Metals, has invested AU$3 million in the Ian Frazer-backed biotech company Coridon, which is developing DNA vaccines for a
